RSVP for a One-on-One Hands-On Training
and Product Samples (Limited seats/inventory, First come-first served)
The 2023 ASRM Scientific Congress & Expo in New Orleans, Louisiana offers new CME and hands-on training sessions led by industry experts featuring the latest advancements in streamlined fertility diagnostics using ExEm® Foam and the HyFoSy Procedure. Participants will have the opportunity to enhance ultrasound skills in 2D/3D/4D, gain practical experience, ask questions and interact with peers who share a passion in advancing fertility care. The following training opportunities are available for registered attendees:
CME Course: HOC-01 – 3D/4D Imaging in Reproductive Medicine: A Hands-On Course
(Sold Out Course – stay tuned for possible added seats)
Course link: https://asrm.confex.com/asrm/2023/meetingapp.cgi/Session/5214
Date: Sunday, October 15, 2023
Time: 8:00 AM – 12:00 PM
Location: R02 (Ernest N. Morial Convention Center)
The 2022 ASRM gap analysis showed there was a deficiency in the areas of 3D US, hands-on training for evaluation of the uterus and screening prior to IVF and comparison with hysteroscopy. There is also a gap of knowledge and desire for more information regarding salpingohysteroscopy especially with the new contrast agents for tubal patency evaluation such as ExEm® Foam. There was a continual need for hands-on training and improvement of ultrasound skills. The goal of improving ultrasound skills by the physician and healthcare providers with new technology is to improve diagnostic skills and outcomes for patients with infertility undergoing ART.
This course will provide a fundamental understanding of ultrasound imaging and its clinical benefits in reproductive medicine with specific emphasis on the role of 3D imaging. The use of 3D for evaluation of ovarian reserve, follicle monitoring, uterine anomalies and implantation will be reviewed, as well as performing embryo transfers and early pregnancy evaluation.
Chairs: Laurel Stadtmauer, Eastern Virginia Medical School
Ilan Tur-Kaspa, Institute for Human Reproduction (IHR), Pinnacle Fertility
Faculty: Laura Detti, Baylor College of Medicine
Tomer Singer, Northwell Health Fertility, Zucker School of Medicine at Hofstra/Northwell
Experience ExEm® Foam / HyFoSy: Enhance your Diagnostic Skills
Registration link: https://hubs.la/Q021lBtl0
Dates: Monday, October 16 – October 18, 2023
Time: 8:00 AM – 5:00 PM
Location: Exhibitor Hall, ExEm Foam Booth #428
In partnership with GE HealthCare, the ExEm® Foam Booth will serve as a hub of innovation and education to gain hands-on training and insights into ExEm® Foam and the HyFoSy Procedure using VolusonTM Ultrasound equipment. Elevate your diagnostic skills through this opportunity to interact with cutting-edge technology and imaging techniques, as well as the ExEm® Foam contrast agent.
About the American Society for Reproductive Medicine (ASRM)
ASRM is a multidisciplinary organization dedicated to the advancement of the science and practice of reproductive medicine. The Society accomplishes its mission through the pursuit of excellence in education and research and through advocacy on behalf of patients, physicians, and affiliated health care providers. The Society is committed to facilitating and sponsoring educational activities for the lay public and continuing medical education activities for professionals who are engaged in the practice of and research in reproductive medicine. To learn more about ASRM and the 2022 Scientific Congress and Expo, visit https://www.asrm.org
About ExEm® Foam (air polymer-type A) intrauterine foam
ExEm® Foam ((air polymer-type A) intrauterine foam) is an innovative, FDA-approved product for use in the hysterosalpingo foam sonography (or the HyFoSy). The HyFoSy Procedure is a gentle ultrasound tubal patency assessment for women with known or suspected infertility. During the HyFoSy procedure, ExEm® Foam is infused into the uterus by a healthcare professional and scanned via ultrasound technology to produce a highly echogenic visual assessment of fallopian tubes. If the tubes are patent the foam will be visualized through ultrasound as a thin, bright white line within the fallopian tubes, and will spill over the ovaries and into the peritoneal. If the white line does not appear, the fallopian tubes might be occluded or blocked.
IMPORTANT SAFETY INFORMATION
ExEm® Foam should not be used on patients who are pregnant, have known or suspected lower genital tract inflammation or infection, have had a gynecologic procedure within the last 30 days, have vaginal bleeding, or have known or suspected reproductive tract neoplasia. Common side effects include pelvic and abdominal pain, vasovagal reactions (and associated symptoms such as nausea and faintness), and post-procedure spotting.
Click here for full prescribing information.
About ExEm® Foam Inc
ExEm® Foam Inc is focused on providing solutions to simplify infertility diagnosis and enhance the fertility journey. Drawing on its years of experience, the team develops innovative products that better meet the needs of today’s patient and healthcare professional. ExEm® Foam, the company’s first FDA-approved product, is indicated as a contrast drug for hysterosalpingo foam sonography, also known as HyFoSy, to assess whether there may be a blockage in the fallopian tubes in women with known or suspected infertility. ExEm® Foam has been used in more than 1,000,000 tubal patency procedures worldwide since it first launched in Europe in 2011. ExEm® Foam Inc. is headquartered in Nashville, TN.
For more information, please visit www.exemfoam.com.
